Reevaluating Postnatal Steroids for Extremely Preterm Infants to Prevent Lung Disease

JAMA. 2017 Apr 4;317(13):1317-1318. doi: 10.1001/jama.2017.2725.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Chronic Disease
  • Dexamethasone / therapeutic use*
  • Glucocorticoids / therapeutic use
  • Humans
  • Infant
  • Infant, Extremely Premature*
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / drug therapy
  • Lung Diseases / drug therapy
  • Steroids

Substances

  • Glucocorticoids
  • Steroids
  • Dexamethasone